Kamada Ltd. is a vertically integrated global biopharmaceutical company, specializing in plasma-derived therapeutics for rare and specialty indications. With a diverse portfolio of marketed products, a robust development pipeline, and industry-leading manufacturing capabilities, Kamada is present in over 30 countries, delivering innovative, high-quality plasma therapies.

Since 2021, Torus Pharma has partnered with Kamada to introduce KamRAB to the Romanian market. Through this strategic collaboration, Torus Pharma continues to ensure consistent availability of the product for Romanian patients, providing access to specialized plasma-derived therapy, supporting effective post-exposure rabies prevention and promoting high standards in immunological care.